| 摘要 |
<p>A method for the treatment of arthritis or a related autoimmune disease that exhibits immuns complexes in serums or synovial fluid is provided which comprises exposure of the serum or synovial fluid to an oligosaccharide containing a structural component that inhibits or disrupts the degree of occupancy of the Fc carbohydrate binding site on IgG, e.g., sialyllactose.</p> |
